Alloplex Biotherapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.alloplexbio.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study of SUPLEXA in Patients With Metastatic Solid Tumours and Haematologic Malignancies
Phase 1
Completed
- Conditions
- Oncology
- First Posted Date
- 2022-02-14
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Alloplex Biotherapeutics Inc
- Target Recruit Count
- 35
- Registration Number
- NCT05237206
- Locations
- 🇦🇺
Greenslopes Private Hospital/Gallipoli Medical Research Foundation, Brisbane, Queeensland, Australia
🇦🇺Cancer Research Sa (Crsa), Adelaide, South Australia, Australia
🇦🇺Southern Oncology Clinical Research Unit (SOCRU), Adelaide, South Australia, Australia
News
No news found